Successful Implementation of Biventricular HeartMate 3 Ventricular Assist Devices as Destination Therapy

Journal of Cardiothoracic and Vascular Anesthesia 2026 Open access

Read full text
Authors: Rachel Liedberg, Loren R. Francis, Robert Bowen, Matthew Hulse, Jeffrey McMurray, Callah West, Carlee A. Clark
DOI: 10.1053/j.jvca.2026.01.038
Cited by: 1
References: 5

Abstract

Left ventricular assist devices (LVADs) have revolutionized the management of end-stage heart disease since their FDA approval as bridge-to-transplant therapy in 1994, followed by destination therapy approval in 2002. These devices have dramatically expanded treatment options and improved survival for patients with advanced heart failure. However, patients with biventricular heart failure who are ineligible for heart transplantation face particularly complex management challenges, with limited long-term mechanical circulatory support options [1].

Fields of Study & Subjects

Mechanical Circulatory Support Devices Cardiac Structural Anomalies and Repair Tissue Engineering and Regenerative Medicine

Publication details

Journal / source
Journal of Cardiothoracic and Vascular Anesthesia
Publisher
Elsevier BV
Volume
40
Issue
5
Pages
1468–1471
Publication date
29 January 2026
Language
EN